The article about AICAR
Has anyone out there heard of this new drug or know anything about it? There isn't much info on the web about it. I saw an article in the LA Times about it and wanted some more info...Any assistance would be appreciated!
-Kristina
This is the original article about AICAR. Can't wait to get it!!!
CELL
Volume 134, Issue 3, 8 August 2008, Pages 405-415
doi:10.1016/j.cell.2008.06.051
AMPK and PPARδ Agonists Are Exercise Mimetics
Vihang A. Narkar1, Michael Downes1, Ruth T. Yu1, Emi Embler1, Yong-Xu Wang4, Ester Banayo3, Maria M. Mihaylova2, Michael C. Nelson1, Yuhua Zou1, Henry Juguilon1, Heonjoong Kang5, Reuben J. Shaw2 and Ronald M. Evans1, 3, ,
1Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA 2Molecular and Cell Biology Laboratory, Salk Institute, La Jolla, CA 92037, USA 3Howard Hughes Medical Institute, La Jolla, CA 92037, USA 4University of Massachusetts Medical School, Worcester, MA 01605, USA 5Marine Biotechnology Laboratory, School of Earth and Environmental Sciences, Seoul National University, Seoul 151-747, South Korea
Received 30 May 2007; revised 23 April 2008; accepted 20 June 2008. Published online: July 31, 2008. Available online 31 July 2008.
Can Exercise Mimetics Substitute for Exercise?
Cell Metabolism, Volume 8, Issue 2, 6 August 2008, Pages 96-98
Erik A. Richter, Bente Kiens, Jørgen F.P. Wojtaszewski
PDF (202 K)
Summary
The benefits of endurance exercise on general health make it desirable to identify orally active agents that would mimic or potentiate the effects of exercise to treat metabolic diseases. Although certain natural compounds, such as reseveratrol, have endurance-enhancing activities, their exact metabolic targets remain elusive. We therefore tested the effect of pathway-specific drugs on endurance capacities of mice in a treadmill running test.
We found that PPARβ/δ agonist and exercise training synergistically increase oxidative myofibers and running endurance in adult mice. Because training activates AMPK and PGC1α, we then tested whether the orally active AMPK agonist AICAR might be sufficient to overcome the exercise requirement. Unexpectedly, even in sedentary mice, 4 weeks of AICAR treatment alone induced metabolic genes and enhanced running endurance by 44%. These results demonstrate that AMPK-PPARδ pathway can be targeted by orally active drugs to enhance training adaptation or even to increase endurance without exercise.
Author Keywords: SIGNALING